Holocene Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,607
Closed -$713K 784
2022
Q2
$713K Buy
+50,607
New +$713K ﹤0.01% 682
2021
Q2
Hold
0
790
2021
Q1
Hold
0
772
2018
Q2
Sell
-10,047
Closed -$226K 548
2018
Q1
$226K Sell
10,047
-1,021
-9% -$23K 0.01% 490
2017
Q4
$333K Buy
+11,068
New +$333K 0.01% 513